The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...
Anza, a subscription-based data and analytics software platform, released its Q2 2025 Domestic Content Insights report that reveals trends in domestic manufacturing of solar modules and battery energy ...
Toyo Solar plans to transport its cells to a module manufacturing facility in the US. Image: Toyo Solar. Japanese cell and module manufacturer Toyo Solar plans to double its annual solar PV cell ...
The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results